Global Cancer & Tumor Profiling and Pathways Supply, Demand and Key Producers, 2023-2029

Page: 104

Published Date: 30 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Cancer & Tumor Profiling and Pathways market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Cancer & Tumor Profiling and Pathways demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer & Tumor Profiling and Pathways, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer & Tumor Profiling and Pathways that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cancer & Tumor Profiling and Pathways total market, 2018-2029, (USD Million)
Global Cancer & Tumor Profiling and Pathways total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cancer & Tumor Profiling and Pathways total market, key domestic companies and share, (USD Million)
Global Cancer & Tumor Profiling and Pathways revenue by player and market share 2018-2023, (USD Million)
Global Cancer & Tumor Profiling and Pathways total market by Type, CAGR, 2018-2029, (USD Million)
Global Cancer & Tumor Profiling and Pathways total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cancer & Tumor Profiling and Pathways market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US), HTG Molecular Diagnostics, Inc. (US) and Sysmex Corporation (Japan), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer & Tumor Profiling and Pathways market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cancer & Tumor Profiling and Pathways Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cancer & Tumor Profiling and Pathways Market, Segmentation by Type
    Immunoassays
    Next Generation Sequencing (NGS)
    Polymerase Chain Reaction (PCR)
    In-Situ Hybridization (ISH)
    Microarrays
    Mass Spectrometry
    Others

Global Cancer & Tumor Profiling and Pathways Market, Segmentation by Application
    Research
    Clinical

Companies Profiled:
    Illumina, Inc. (US)
    QIAGEN N.V. (Germany)
    NeoGenomics Laboratories, Inc. (US)
    HTG Molecular Diagnostics, Inc. (US)
    Sysmex Corporation (Japan)

Key Questions Answered
1. How big is the global Cancer & Tumor Profiling and Pathways market?
2. What is the demand of the global Cancer & Tumor Profiling and Pathways market?
3. What is the year over year growth of the global Cancer & Tumor Profiling and Pathways market?
4. What is the total value of the global Cancer & Tumor Profiling and Pathways market?
5. Who are the major players in the global Cancer & Tumor Profiling and Pathways market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cancer & Tumor Profiling and Pathways Introduction
    1.2 World Cancer & Tumor Profiling and Pathways Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Cancer & Tumor Profiling and Pathways Total Market by Region (by Headquarter Location)
        1.3.1 World Cancer & Tumor Profiling and Pathways Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Cancer & Tumor Profiling and Pathways Market Size (2018-2029)
        1.3.3 China Cancer & Tumor Profiling and Pathways Market Size (2018-2029)
        1.3.4 Europe Cancer & Tumor Profiling and Pathways Market Size (2018-2029)
        1.3.5 Japan Cancer & Tumor Profiling and Pathways Market Size (2018-2029)
        1.3.6 South Korea Cancer & Tumor Profiling and Pathways Market Size (2018-2029)
        1.3.7 ASEAN Cancer & Tumor Profiling and Pathways Market Size (2018-2029)
        1.3.8 India Cancer & Tumor Profiling and Pathways Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cancer & Tumor Profiling and Pathways Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cancer & Tumor Profiling and Pathways Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)
    2.2 World Cancer & Tumor Profiling and Pathways Consumption Value by Region
        2.2.1 World Cancer & Tumor Profiling and Pathways Consumption Value by Region (2018-2023)
        2.2.2 World Cancer & Tumor Profiling and Pathways Consumption Value Forecast by Region (2024-2029)
    2.3 United States Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)
    2.4 China Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)
    2.5 Europe Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)
    2.6 Japan Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)
    2.7 South Korea Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)
    2.8 ASEAN Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)
    2.9 India Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029)

3 World Cancer & Tumor Profiling and Pathways Companies Competitive Analysis
    3.1 World Cancer & Tumor Profiling and Pathways Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cancer & Tumor Profiling and Pathways Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cancer & Tumor Profiling and Pathways in 2022
        3.2.3 Global Concentration Ratios (CR8) for Cancer & Tumor Profiling and Pathways in 2022
    3.3 Cancer & Tumor Profiling and Pathways Company Evaluation Quadrant
    3.4 Cancer & Tumor Profiling and Pathways Market: Overall Company Footprint Analysis
        3.4.1 Cancer & Tumor Profiling and Pathways Market: Region Footprint
        3.4.2 Cancer & Tumor Profiling and Pathways Market: Company Product Type Footprint
        3.4.3 Cancer & Tumor Profiling and Pathways Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cancer & Tumor Profiling and Pathways Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cancer & Tumor Profiling and Pathways Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Cancer & Tumor Profiling and Pathways Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Cancer & Tumor Profiling and Pathways Consumption Value Comparison
        4.2.1 United States VS China: Cancer & Tumor Profiling and Pathways Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cancer & Tumor Profiling and Pathways Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Cancer & Tumor Profiling and Pathways Companies and Market Share, 2018-2023
        4.3.1 United States Based Cancer & Tumor Profiling and Pathways Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cancer & Tumor Profiling and Pathways Revenue, (2018-2023)
    4.4 China Based Companies Cancer & Tumor Profiling and Pathways Revenue and Market Share, 2018-2023
        4.4.1 China Based Cancer & Tumor Profiling and Pathways Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cancer & Tumor Profiling and Pathways Revenue, (2018-2023)
    4.5 Rest of World Based Cancer & Tumor Profiling and Pathways Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Cancer & Tumor Profiling and Pathways Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cancer & Tumor Profiling and Pathways Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Cancer & Tumor Profiling and Pathways Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Immunoassays
        5.2.2 Next Generation Sequencing (NGS)
        5.2.3 Polymerase Chain Reaction (PCR)
        5.2.4 In-Situ Hybridization (ISH)
        5.2.5 Microarrays
        5.2.6 Mass Spectrometry
        5.2.7 Others
    5.3 Market Segment by Type
        5.3.1 World Cancer & Tumor Profiling and Pathways Market Size by Type (2018-2023)
        5.3.2 World Cancer & Tumor Profiling and Pathways Market Size by Type (2024-2029)
        5.3.3 World Cancer & Tumor Profiling and Pathways Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cancer & Tumor Profiling and Pathways Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Research
        6.2.2 Clinical
    6.3 Market Segment by Application
        6.3.1 World Cancer & Tumor Profiling and Pathways Market Size by Application (2018-2023)
        6.3.2 World Cancer & Tumor Profiling and Pathways Market Size by Application (2024-2029)
        6.3.3 World Cancer & Tumor Profiling and Pathways Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Illumina, Inc. (US)
        7.1.1 Illumina, Inc. (US) Details
        7.1.2 Illumina, Inc. (US) Major Business
        7.1.3 Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Product and Services
        7.1.4 Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Illumina, Inc. (US) Recent Developments/Updates
        7.1.6 Illumina, Inc. (US) Competitive Strengths & Weaknesses
    7.2 QIAGEN N.V. (Germany)
        7.2.1 QIAGEN N.V. (Germany) Details
        7.2.2 QIAGEN N.V. (Germany) Major Business
        7.2.3 QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Product and Services
        7.2.4 QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 QIAGEN N.V. (Germany) Recent Developments/Updates
        7.2.6 QIAGEN N.V. (Germany) Competitive Strengths & Weaknesses
    7.3 NeoGenomics Laboratories, Inc. (US)
        7.3.1 NeoGenomics Laboratories, Inc. (US) Details
        7.3.2 NeoGenomics Laboratories, Inc. (US) Major Business
        7.3.3 NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Product and Services
        7.3.4 NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 NeoGenomics Laboratories, Inc. (US) Recent Developments/Updates
        7.3.6 NeoGenomics Laboratories, Inc. (US) Competitive Strengths & Weaknesses
    7.4 HTG Molecular Diagnostics, Inc. (US)
        7.4.1 HTG Molecular Diagnostics, Inc. (US) Details
        7.4.2 HTG Molecular Diagnostics, Inc. (US) Major Business
        7.4.3 HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Product and Services
        7.4.4 HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 HTG Molecular Diagnostics, Inc. (US) Recent Developments/Updates
        7.4.6 HTG Molecular Diagnostics, Inc. (US) Competitive Strengths & Weaknesses
    7.5 Sysmex Corporation (Japan)
        7.5.1 Sysmex Corporation (Japan) Details
        7.5.2 Sysmex Corporation (Japan) Major Business
        7.5.3 Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Product and Services
        7.5.4 Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Sysmex Corporation (Japan) Recent Developments/Updates
        7.5.6 Sysmex Corporation (Japan) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cancer & Tumor Profiling and Pathways Industry Chain
    8.2 Cancer & Tumor Profiling and Pathways Upstream Analysis
    8.3 Cancer & Tumor Profiling and Pathways Midstream Analysis
    8.4 Cancer & Tumor Profiling and Pathways Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cancer & Tumor Profiling and Pathways Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Cancer & Tumor Profiling and Pathways Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Cancer & Tumor Profiling and Pathways Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Cancer & Tumor Profiling and Pathways Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Cancer & Tumor Profiling and Pathways Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cancer & Tumor Profiling and Pathways Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Cancer & Tumor Profiling and Pathways Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Cancer & Tumor Profiling and Pathways Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Cancer & Tumor Profiling and Pathways Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Cancer & Tumor Profiling and Pathways Players in 2022
    Table 12. World Cancer & Tumor Profiling and Pathways Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Cancer & Tumor Profiling and Pathways Company Evaluation Quadrant
    Table 14. Head Office of Key Cancer & Tumor Profiling and Pathways Player
    Table 15. Cancer & Tumor Profiling and Pathways Market: Company Product Type Footprint
    Table 16. Cancer & Tumor Profiling and Pathways Market: Company Product Application Footprint
    Table 17. Cancer & Tumor Profiling and Pathways Mergers & Acquisitions Activity
    Table 18. United States VS China Cancer & Tumor Profiling and Pathways Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Cancer & Tumor Profiling and Pathways Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Cancer & Tumor Profiling and Pathways Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cancer & Tumor Profiling and Pathways Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Cancer & Tumor Profiling and Pathways Revenue Market Share (2018-2023)
    Table 23. China Based Cancer & Tumor Profiling and Pathways Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cancer & Tumor Profiling and Pathways Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Cancer & Tumor Profiling and Pathways Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Cancer & Tumor Profiling and Pathways Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cancer & Tumor Profiling and Pathways Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Cancer & Tumor Profiling and Pathways Revenue Market Share (2018-2023)
    Table 29. World Cancer & Tumor Profiling and Pathways Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Cancer & Tumor Profiling and Pathways Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Cancer & Tumor Profiling and Pathways Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Cancer & Tumor Profiling and Pathways Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Cancer & Tumor Profiling and Pathways Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Cancer & Tumor Profiling and Pathways Market Size by Application (2024-2029) & (USD Million)
    Table 35. Illumina, Inc. (US) Basic Information, Area Served and Competitors
    Table 36. Illumina, Inc. (US) Major Business
    Table 37. Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Product and Services
    Table 38. Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Illumina, Inc. (US) Recent Developments/Updates
    Table 40. Illumina, Inc. (US) Competitive Strengths & Weaknesses
    Table 41. QIAGEN N.V. (Germany) Basic Information, Area Served and Competitors
    Table 42. QIAGEN N.V. (Germany) Major Business
    Table 43. QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Product and Services
    Table 44. QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. QIAGEN N.V. (Germany) Recent Developments/Updates
    Table 46. QIAGEN N.V. (Germany) Competitive Strengths & Weaknesses
    Table 47. NeoGenomics Laboratories, Inc. (US) Basic Information, Area Served and Competitors
    Table 48. NeoGenomics Laboratories, Inc. (US) Major Business
    Table 49. NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Product and Services
    Table 50. NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. NeoGenomics Laboratories, Inc. (US) Recent Developments/Updates
    Table 52. NeoGenomics Laboratories, Inc. (US) Competitive Strengths & Weaknesses
    Table 53. HTG Molecular Diagnostics, Inc. (US) Basic Information, Area Served and Competitors
    Table 54. HTG Molecular Diagnostics, Inc. (US) Major Business
    Table 55. HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Product and Services
    Table 56. HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. HTG Molecular Diagnostics, Inc. (US) Recent Developments/Updates
    Table 58. Sysmex Corporation (Japan) Basic Information, Area Served and Competitors
    Table 59. Sysmex Corporation (Japan) Major Business
    Table 60. Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Product and Services
    Table 61. Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 62. Global Key Players of Cancer & Tumor Profiling and Pathways Upstream (Raw Materials)
    Table 63. Cancer & Tumor Profiling and Pathways Typical Customers
List of Figure
    Figure 1. Cancer & Tumor Profiling and Pathways Picture
    Figure 2. World Cancer & Tumor Profiling and Pathways Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cancer & Tumor Profiling and Pathways Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Cancer & Tumor Profiling and Pathways Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cancer & Tumor Profiling and Pathways Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Cancer & Tumor Profiling and Pathways Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Cancer & Tumor Profiling and Pathways Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Cancer & Tumor Profiling and Pathways Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Cancer & Tumor Profiling and Pathways Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Cancer & Tumor Profiling and Pathways Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Cancer & Tumor Profiling and Pathways Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Cancer & Tumor Profiling and Pathways Revenue (2018-2029) & (USD Million)
    Figure 13. Cancer & Tumor Profiling and Pathways Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Cancer & Tumor Profiling and Pathways Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Cancer & Tumor Profiling and Pathways Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Cancer & Tumor Profiling and Pathways by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer & Tumor Profiling and Pathways Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer & Tumor Profiling and Pathways Markets in 2022
    Figure 27. United States VS China: Cancer & Tumor Profiling and Pathways Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cancer & Tumor Profiling and Pathways Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Cancer & Tumor Profiling and Pathways Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Cancer & Tumor Profiling and Pathways Market Size Market Share by Type in 2022
    Figure 31. Immunoassays
    Figure 32. Next Generation Sequencing (NGS)
    Figure 33. Polymerase Chain Reaction (PCR)
    Figure 34. In-Situ Hybridization (ISH)
    Figure 35. Microarrays
    Figure 36. Mass Spectrometry
    Figure 37. Others
    Figure 38. World Cancer & Tumor Profiling and Pathways Market Size Market Share by Type (2018-2029)
    Figure 39. World Cancer & Tumor Profiling and Pathways Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Cancer & Tumor Profiling and Pathways Market Size Market Share by Application in 2022
    Figure 41. Research
    Figure 42. Clinical
    Figure 43. Cancer & Tumor Profiling and Pathways Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Illumina, Inc. (US)
QIAGEN N.V. (Germany)
NeoGenomics Laboratories, Inc. (US)
HTG Molecular Diagnostics, Inc. (US)
Sysmex Corporation (Japan)

Related Reports

Global Cancer & Tumor Profiling and Pathways Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Cancer & Tumor Profiling and Pathways Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 01 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Cancer & Tumor Profiling and Pathways market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Cancer & Tumor Profiling and Pathways Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cancer & Tumor Profiling and Pathways Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Cancer & Tumor Profiling and Pathways market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Cancer & Tumor Profiling and Pathways

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>